INTRODUCTIONVitiligo can significantly impact the quality of life of affected individuals and their family members. Support groups provide numerous benefits, including allowing individuals to give and receive emotional and practical…
Read More
INTRODUCTIONNonmelanoma skin cancer (NMSC) is the most common malignancy in the United States, and a growing public health concern.1 While a variety of prevention strategies exist for high-risk groups such…
Read More
INTRODUCTIONTildrakizumab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds the p19 subunit of interleukin-23 (IL-23), a key cytokine in the pathogenesis of psoriasis.1-4 In the pivotal phase…
Read More
In this article:Tildrakizumab for Real-World Psoriasis Care: Clinical Lessons From Medically Complex and Underserved Patient Populations Tildrakizumab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds the p19…
Read More
INTRODUCTIONThe skin barrier is a highly organized system in which structural proteins, intercellular lipids, and natural moisturizing factors (NMFs) work together to maintain moisture content, regulate desquamation, and protect against…
Read More
INTRODUCTIONXerotic and hyperkeratotic skin conditions represent a substantial proportion of dermatologic consultations and are associated with both physical discomfort and psychosocial burden. These conditions encompass a wide spectrum of disorders,…
Read More
In this issue: Beyond Moisturization: Ammonium Lactate as a Biomimetic Regulator of Skin Barrier Function The skin barrier is a highly organized system in which structural proteins, intercellular lipids, and…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a common inflammatory skin disease with a relapsing and remitting course over a patient's lifetime.1,2 This chronic skin condition is estimated to affect up to 20%…
Read More
INTRODUCTIONSeborrheic dermatitis (SD) is a chronic, relapsing inflammatory condition that predominantly affects sebaceous gland-rich areas such as the scalp, face, and chest.1 Characterized by erythematous scaly patches, SD affects up…
Read More
INTRODUCTIONMenopause is a physiological stage in a woman's life characterized by the permanent cessation of ovarian follicular activity and a consequent decline in circulating estrogen levels. This transition reflects a…
Read More
INTRODUCTIONChronic pruritus remains one of the most challenging symptoms to manage across dermatologic and systemic conditions, significantly impairing quality of life and often proving refractory to conventional therapies. Nemolizumab represents…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a chronic inflammatory skin condition that typically begins in infancy, peaks in early childhood, and persists into adulthood.1,2 Clinical features of pediatric AD include a relapsing…
Read More
